Abstract
The IE62 protein, the primary regulatory protein of varicella-zoster virus (VZV) and the major component of the virion tegument, was an effective immunogen in the guinea pig model of VZV infection, whereas the ORF 29 gene product, a nonstructural DNA replication protein, did not elicit protection. All animals immunized with the ORF 29 protein had cell-associated viremia compared with 2 of 11 guinea pigs given the IE62 protein (P = 0.005). VZV was detected in ganglia from 38% of the animals given the ORF 29 protein and 44% of the control animals compared with 9% of the animals immunized with the IE62 protein (P = 0.04). In contrast to the IE62 protein, immunization with the ORF 29 protein did not prime the animals for an enhanced T-cell response upon challenge with infectious virus. The VZV IE62 protein has potential value as a vaccine component.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Chickenpox / prevention & control*
-
DNA-Binding Proteins / immunology
-
DNA-Binding Proteins / therapeutic use
-
Ganglia / microbiology
-
Guinea Pigs
-
Immediate-Early Proteins / immunology
-
Immediate-Early Proteins / therapeutic use*
-
Immunization*
-
Leukocytes, Mononuclear / microbiology
-
T-Lymphocytes / immunology
-
Trans-Activators / immunology
-
Trans-Activators / therapeutic use*
-
Trigeminal Ganglion / microbiology
-
Viral Envelope Proteins / genetics
-
Viral Envelope Proteins / immunology
-
Viral Envelope Proteins / therapeutic use*
-
Viral Vaccines / immunology
-
Viral Vaccines / therapeutic use*
-
Viremia / prevention & control
-
Weaning
Substances
-
DNA-Binding Proteins
-
IE62 protein, Human herpesvirus 3
-
Immediate-Early Proteins
-
Trans-Activators
-
Viral Envelope Proteins
-
Viral Vaccines
-
glycoprotein gp2, varicella-zoster virus